Managment of acute esophageal variceal bleeding
DOI:
https://doi.org/10.12775/JEHS.2024.52.002Keywords
esophageal variceal hemorrhage, transjugular intrahepatic portosystemic shunt, balloon tamponade, self-expanding metallic stents, endoscopic variceal ligationAbstract
Krwawienie z żylaków przełyku jest poważnym powikłaniem nadciśnienia wrotnego spowodowanego marskością wątroby. Cele leczenia tej choroby obejmują kontrolę krwotoku, minimalizację ryzyka ponownego krwawienia, zapobieganie powikłaniom i zmniejszenie śmiertelności, co wymaga podejścia wielodyscyplinarnego. W ostrych epizodach interwencje obejmują leki wazoaktywne, antybiotyki i techniki endoskopowe. Klasyfikacja pacjentów przy użyciu gradientu ciśnienia żylnego wątroby (HVPG) i systemów punktacji pomaga w stratyfikacji ryzyka i szybkiej interwencji. Z farmakologicznego punktu widzenia leki wazoaktywne odgrywają kluczową rolę, a nowe strategie, takie jak transfuzja pod kontrolą TEG i wczesne TIPS, przyczyniają się do ewolucji standardów. Ogólnie rzecz biorąc, w ostatnich dziesięcioleciach nastąpił znaczny postęp w leczeniu krwawień z żylaków przełyku, poprawiający wyniki i udoskonalający podejścia terapeutyczne.
References
de Franchis R; Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743-752. doi:10.1016/j.jhep.2015.05.022
Haq I, Tripathi D. Recent advances in the management of variceal bleeding. Gastroenterol Rep (Oxf). 2017;5(2):113-126. doi:10.1093/gastro/gox007
Fortune BE, Garcia-Tsao G, Ciarleglio M, et al. Child-Turcotte-Pugh Class is Best at Stratifying Risk in Variceal Hemorrhage: Analysis of a US Multicenter Prospective Study. J Clin Gastroenterol. 2017;51(5):446-453. doi:10.1097/MCG.0000000000000733
Groszmann RJ, Bosch J, Grace ND, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology. 1990;99(5):1401-1407. doi:10.1016/0016-5085(90)91168-6
Kovalak M, Lake J, Mattek N, Eisen G, Lieberman D, Zaman A. Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database. Gastrointest Endosc. 2007;65(1):82-88. doi:10.1016/j.gie.2006.08.023
Danuta Celińska-Cedro - Prevention and treatment of bleeding from esophageal varices - diagnostic and search strategy. Clinical Gastroenterology. Progress and Standard. 2011;3(4):159-166.
Edelson J, Basso JE, Rockey DC. Updated strategies in the management of acute variceal haemorrhage. Curr Opin Gastroenterol. 2021;37(3):167-172. doi:10.1097/MOG.0000000000000723
Odutayo A, Desborough MJ, Trivella M, et al. Restrictive versus liberal blood transfusion for gastrointestinal bleeding: a systematic review and meta-analysis of randomised controlled trials. Lancet Gastroenterol Hepatol. 2017;2(5):354-360. doi:10.1016/S2468-1253(17)30054-7
Rout G, Shalimar, Gunjan D, et al. Thromboelastography-guided Blood Product Transfusion in Cirrhosis Patients With Variceal Bleeding: A Randomized Controlled Trial. J Clin Gastroenterol. 2020;54(3):255-262. doi:10.1097/MCG.0000000000001214
Powell M, Journey JD. Sengstaken-Blakemore Tube. In: StatPearls. Treasure Island (FL): StatPearls Publishing; May 29, 2023.
Choi JY, Jo YW, Lee SS, et al. Outcomes of patients treated with Sengstaken-Blakemore tube for uncontrolled variceal hemorrhage. Korean J Intern Med. 2018;33(4):696-704. doi:10.3904/kjim.2016.339
Seet E, Beevee S, Cheng A, Lim E. The Sengstaken-Blakemore tube: uses and abuses. Singapore Med J. 2008;49(8):e195-e197.
Vangeli M, Patch D, Burroughs AK. Salvage tips for uncontrolled variceal bleeding. J Hepatol. 2002;37(5):703-704. doi:10.1016/s0168-8278(02)00321-5
Ibrahim M, El-Mikkawy A, Abdalla H, Mostafa I, Devière J. Management of acute variceal bleeding using hemostatic powder. United European Gastroenterol J. 2015;3(3):277-283. doi:10.1177/2050640615570148
Ibrahim M, El-Mikkawy A, Abdel Hamid M, et al. Early application of haemostatic powder added to standard management for oesophagogastric variceal bleeding: a randomised trial. Gut. 2019;68(5):844-853. doi:10.1136/gutjnl-2017-314653
Bernard B, Cadranel JF, Valla D, Escolano S, Jarlier V, Opolon P. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology. 1995;108(6):1828-1834. doi:10.1016/0016-5085(95)90146-9
Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila F, et al. Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review. Aliment Pharmacol Ther. 2011;34(5):509-518. doi:10.1111/j.1365-2036.2011.04746.x
Tandon P, Abraldes JG, Keough A, et al. Risk of Bacterial Infection in Patients With Cirrhosis and Acute Variceal Hemorrhage, Based on Child-Pugh Class, and Effects of Antibiotics. Clin Gastroenterol Hepatol. 2015;13(6):1189-96.e2. doi:10.1016/j.cgh.2014.11.019
Fernández J, Ruiz del Arbol L, Gómez C, et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology. 2006;131(4):1049-1285. doi:10.1053/j.gastro.2006.07.010
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis [published correction appears in J Hepatol. 2018 Nov;69(5):1207]. J Hepatol. 2018;69(2):406-460. doi:10.1016/j.jhep.2018.03.024
Hsu YC, Chung CS, Tseng CH, et al. Delayed endoscopy as a risk factor for in-hospital mortality in cirrhotic patients with acute variceal hemorrhage. J Gastroenterol Hepatol. 2009;24(7):1294-1299. doi:10.1111/j.1440-1746.2009.05903.x
Elsebaey MA, Tawfik MA, Ezzat S, Selim A, Elashry H, Abd-Elsalam S. Endoscopic injection sclerotherapy versus N-Butyl-2 Cyanoacrylate injection in the management of actively bleeding esophageal varices: a randomized controlled trial. BMC Gastroenterol. 2019;19(1):23. Published 2019 Feb 4. doi:10.1186/s12876-019-0940-1
Triantos C, Kalafateli M. Endoscopic treatment of esophageal varices in patients with liver cirrhosis. World J Gastroenterol. 2014;20(36):13015-13026. doi:10.3748/wjg.v20.i36.13015
Jung DH, Huh CW, Kim NJ, Kim BW. Optimal endoscopy timing in patients with acute variceal bleeding: A systematic review and meta-analysis. Sci Rep. 2020;10(1):4046. Published 2020 Mar 4. doi:10.1038/s41598-020-60866-x
Vangeli M, Patch D, Burroughs AK. Salvage tips for uncontrolled variceal bleeding. J Hepatol. 2002;37(5):703-704. doi:10.1016/s0168-8278(02)00321-5
García-Pagán JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362(25):2370-2379. doi:10.1056/NEJMoa0910102
Garcia-Pagán JC, Di Pascoli M, Caca K, et al. Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. J Hepatol. 2013;58(1):45-50. doi:10.1016/j.jhep.2012.08.020
Rudler M, Cluzel P, Corvec TL, et al. Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival. Aliment Pharmacol Ther. 2014;40(9):1074-1080. doi:10.1111/apt.12934
Moitinho E, Escorsell A, Bandi JC, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology. 1999;117(3):626-631. doi:10.1016/s0016-5085(99)70455-5
Abraldes JG, Villanueva C, Bañares R, et al. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol. 2008;48(2):229-236. doi:10.1016/j.jhep.2007.10.008
Li S, Zhang C, Lin LL, et al. Early-TIPS Versus Current Standard Therapy for Acute Variceal Bleeding in Cirrhosis Patients: A Systemic Review With Meta-analysis. Front Pharmacol. 2020;11:603. Published 2020 May 20. doi:10.3389/fphar.2020.00603
Wells M, Chande N, Adams P, et al. Meta-analysis: vasoactive medications for the management of acute variceal bleeds. Aliment Pharmacol Ther. 2012;35(11):1267-1278. doi:10.1111/j.1365-2036.2012.05088.x
Seo YS, Park SY, Kim MY, et al. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage. Hepatology. 2014;60(3):954-963. doi:10.1002/hep.27006
Rengasamy S, Ali SM, Sistla SC, Lakshmi CP, Harichandra Kumar KT. Comparison of 2 days versus 5 days of octreotide infusion along with endoscopic therapy in preventing early rebleed from esophageal varices: a randomized clinical study. Eur J Gastroenterol Hepatol. 2015;27(4):386-392. doi:10.1097/MEG.0000000000000300
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Radosław Cymer, Karolina Jurasz, Dominika Podgórska, Ewa Rzeska, Miłosz Sanecki, Karolina Tomczyk, Natalia Chojnacka, Jakub Klarycki
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 408
Number of citations: 0
